FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.5901
-0.0301 (-4.85%)
At close: Aug 29, 2025, 4:00 PM
0.5901
0.00 (0.00%)
After-hours: Aug 29, 2025, 4:00 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $24.67 million as of August 29, 2025. Its market cap has decreased by -62.67% in one year.
Market Cap
24.67M
Enterprise Value
27.26M
1-Year Change
-62.67%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $24.67M, a decrease of -97.39%. That is a compound annual growth rate of -90.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 25.98M | -62.98% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |